Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04176081
Title Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer (SChLAP/IDC)
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

prostate adenocarcinoma

Therapies

Darolutamide + Degarelix

Age Groups: senior | adult
Covered Countries CAN


No variant requirements are available.